Alexa Wonnacott

963 total citations
13 papers, 576 citations indexed

About

Alexa Wonnacott is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Alexa Wonnacott has authored 13 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Cancer Research. Recurrent topics in Alexa Wonnacott's work include Chronic Kidney Disease and Diabetes (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Alexa Wonnacott is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Alexa Wonnacott collaborates with scholars based in United Kingdom and Sweden. Alexa Wonnacott's co-authors include Aled O. Phillips, Soma Meran, Bethan Amphlett, Bnar Talabani, Donald Fraser, Timothy Bowen, Kate Simpson, Apexa Kuverji, William G. Herrington and Alistair Roddick and has published in prestigious journals such as Advanced Drug Delivery Reviews, American Journal Of Pathology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Alexa Wonnacott

12 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexa Wonnacott United Kingdom 9 282 186 142 79 70 13 576
Kai Uwe Eckardt Germany 7 177 0.6× 52 0.3× 46 0.3× 34 0.4× 13 0.2× 9 360
Douglas A. Thompson Canada 3 156 0.6× 100 0.5× 24 0.2× 44 0.6× 45 0.6× 7 379
H. Barle Sweden 12 68 0.2× 70 0.4× 19 0.1× 79 1.0× 29 0.4× 24 426
Asora Fux Israel 12 95 0.3× 85 0.5× 29 0.2× 54 0.7× 17 0.2× 19 530
Chenfei Zheng China 11 148 0.5× 59 0.3× 26 0.2× 40 0.5× 10 0.1× 22 347
Serpil Müge Değer Türkiye 17 259 0.9× 135 0.7× 16 0.1× 42 0.5× 15 0.2× 45 592
Pamela D. Winterberg United States 13 191 0.7× 195 1.0× 21 0.1× 13 0.2× 11 0.2× 22 634
Huaizhou You China 11 193 0.7× 77 0.4× 9 0.1× 18 0.2× 27 0.4× 24 444
Shiwori Osada Japan 12 269 1.0× 125 0.7× 26 0.2× 81 1.0× 4 0.1× 26 518

Countries citing papers authored by Alexa Wonnacott

Since Specialization
Citations

This map shows the geographic impact of Alexa Wonnacott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa Wonnacott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa Wonnacott more than expected).

Fields of papers citing papers by Alexa Wonnacott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexa Wonnacott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa Wonnacott. The network helps show where Alexa Wonnacott may publish in the future.

Co-authorship network of co-authors of Alexa Wonnacott

This figure shows the co-authorship network connecting the top 25 collaborators of Alexa Wonnacott. A scholar is included among the top collaborators of Alexa Wonnacott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexa Wonnacott. Alexa Wonnacott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Roddick, Alistair, Alexa Wonnacott, David R. Webb, et al.. (2023). UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE. BMC Nephrology. 24(1). 310–310. 37 indexed citations
2.
Staplin, Natalie, Alistair Roddick, Jonathan Emberson, et al.. (2021). Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials. EClinicalMedicine. 41. 101163–101163. 41 indexed citations
3.
Wonnacott, Alexa, Laura Denby, Richard J. Coward, Donald Fraser, & Timothy Bowen. (2021). MicroRNAs and their delivery in diabetic fibrosis. Advanced Drug Delivery Reviews. 182. 114045–114045. 30 indexed citations
4.
Newbury, Lucy J., Alexa Wonnacott, Kate Simpson, Timothy Bowen, & Donald Fraser. (2019). Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients. Methods in molecular biology. 2067. 277–285. 3 indexed citations
5.
Beltrami, Cristina, Kate Simpson, Mark Jesky, et al.. (2018). Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease. American Journal Of Pathology. 188(9). 1982–1992. 66 indexed citations
6.
Simpson, Kate, Alexa Wonnacott, Donald Fraser, & Timothy Bowen. (2016). MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy. Current Diabetes Reports. 16(3). 35–35. 119 indexed citations
7.
Johnson, Faye M., et al.. (2015). The impact of acute kidney injury in diabetes mellitus. Nephrology. 21(6). 506–511. 18 indexed citations
8.
Wonnacott, Alexa, Soma Meran, Bethan Amphlett, Bnar Talabani, & Aled O. Phillips. (2014). Epidemiology and Outcomes in Community-Acquired Versus Hospital-Acquired AKI. Clinical Journal of the American Society of Nephrology. 9(6). 1007–1014. 211 indexed citations
9.
Meran, Soma, Alexa Wonnacott, Bethan Amphlett, & Aled O. Phillips. (2014). How good are we at managing acute kidney injury in hospital?. Clinical Kidney Journal. 7(2). 144–150. 21 indexed citations
10.
Meran, Soma, et al.. (2013). A simple screening test for the detection of erythropoietin antibodies. Clinical Nephrology. 82(3). 215–20.
11.
Wonnacott, Alexa, Soma Meran, Gareth Roberts, et al.. (2012). Applying estimated glomerular filtration rate to an ageing population: are we in danger of becoming ageist?. European Journal of Internal Medicine. 23(8). 705–710. 1 indexed citations
12.
Miller, Andrew S., Alexa Wonnacott, & William J. McBride. (2012). Dengue Induced Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone. Journal of Clinical Case Reports. 2(3). 4 indexed citations
13.
Ahmadi, Ahmad, et al.. (2006). Association of Insulin-Like Growth Factor-1 Receptor Polymorphism in Dementia. Dementia and Geriatric Cognitive Disorders. 22(5-6). 439–444. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Uwe Eckardt Breakdown of academic impact, for papers by Douglas A. Thompson Breakdown of academic impact, for papers by H. Barle Breakdown of academic impact, for papers by Asora Fux Breakdown of academic impact, for papers by Chenfei Zheng Breakdown of academic impact, for papers by Serpil Müge Değer Breakdown of academic impact, for papers by Pamela D. Winterberg Breakdown of academic impact, for papers by Huaizhou You Breakdown of academic impact, for papers by Shiwori Osada
Rankless by CCL
2026